tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Graham Perry, 8 are a BUY (44.44%), 9 are a HOLD (50%), 1 are a SELL (5.56%).
Analyst Graham Perry, currently employed at BAML, carries an average stock price target met ratio of 66.67% that have a potential upside of 59.56% achieved within 2647 days.
Graham Perry’s has documented 27 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on GSK, GlaxoSmithKline PLC ADR at 24-Jul-2026.
Analyst best performing recommendations are on NVS (NOVARTIS AG ADR).
The best stock recommendation documented was for NVS (NOVARTIS AG ADR) at 9/12/2023. The price target of $122.97 was fulfilled within 708 days with a profit of $32.22 (35.5%) receiving and performance score of 0.5.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 26-Mar-2026
$170
$24.54 (16.87%)
6 months ago
(26-Mar-2026)
13/14 (92.86%)
$20.3 (13.56%)
678
Hold Since 11-Mar-2026
$180
$33.97 (23.26%)
$105
6 months 15 days ago
(11-Mar-2026)
1/2 (50%)
$24.2 (15.53%)
1814
Buy Since 28-Mar-2023
$130
7 months 26 days ago
(31-Jan-2026)
3/3 (100%)
$22.14 (20.53%)
656
Hold Since 03-Jan-2023
9 months 18 days ago
(08-Dec-2025)
13/13 (100%)
$8.66 (9.99%)
529
Hold Since 14-Dec-2022
10 months 30 days ago
(27-Oct-2025)
2/2 (100%)
$9.94 (12.43%)
809
Which stock is Graham Perry most bullish on?
Which stock is Graham Perry most reserved on?
What Year was the first public recommendation made by Graham Perry?
